Novozymes A/S
Stock Forecast, Prediction & Price Target
Novozymes A/S Financial Estimates
Novozymes A/S Revenue Estimates
Novozymes A/S EBITDA Estimates
Novozymes A/S Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $14.95B N/A | $17.55B 17.40% | $17.89B 1.97% | Avg: $30.87B Low: $30.87B High: $30.87B avg. 72.47% | Avg: $33.04B Low: $33.04B High: $33.04B avg. 7.03% | Avg: $35.21B Low: $35.21B High: $35.21B avg. 6.58% | Avg: $38.03B Low: $38.03B High: $38.03B avg. 7.99% |
Net Income
% change YoY
| $3.14B N/A | $3.67B 16.84% | $3.02B -17.73% | Avg: $3.92B Low: $3.84B High: $3.99B avg. 29.69% | Avg: $4.34B Low: $4.34B High: $4.34B avg. 10.69% | Avg: $4.64B Low: $4.64B High: $4.64B avg. 7.08% | Avg: $4.88B Low: $4.88B High: $4.88B avg. 5.01% |
EBITDA
% change YoY
| $5.19B N/A | $6.07B 16.87% | $5.47B -9.92% | Avg: $10.44B Low: $10.44B High: $10.44B avg. 90.83% | Avg: $11.17B Low: $11.17B High: $11.17B avg. 7.03% | Avg: $11.91B Low: $11.91B High: $11.91B avg. 6.58% | Avg: $12.86B Low: $12.86B High: $12.86B avg. 7.99% |
EPS
% change YoY
| $11.32 N/A | $13.29 17.40% | $10.88 -18.13% | Avg: $14.11 Low: $13.85 High: $14.38 avg. 29.72% | Avg: $15.62 Low: $15.62 High: $15.62 avg. 10.69% | Avg: $16.73 Low: $16.73 High: $16.73 avg. 7.08% | Avg: $17.57 Low: $17.57 High: $17.57 avg. 5.01% |
Operating Expenses
% change YoY
| $4.73B N/A | $5.14B 8.67% | $5.74B 11.59% | Avg: $5.51B Low: $5.51B High: $5.51B avg. -3.97% | Avg: $5.90B Low: $5.90B High: $5.90B avg. 7.03% | Avg: $6.29B Low: $6.29B High: $6.29B avg. 6.58% | Avg: $6.79B Low: $6.79B High: $6.79B avg. 7.99% |
FAQ
What is Novozymes A/S stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 13.12% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is 3.84B, average is 3.92B and high is 3.99B.
What is Novozymes A/S stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 23.52% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $30.87B, average is $30.87B and high is $30.87B.
What is Novozymes A/S stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 13.13% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is $13.85, average is $14.11 and high is $14.37.